Mark Trumbo’s power matched only by his out-making ability

14 Comments

I was watching the Angels-Twins game last night when Minnesota television analyst Bert Blyleven advised Francisco Liriano to “throw the slider to this big donkey.”

Liriano obliged and Mark Trumbo hit the ball approximately 700 feet for a three-run homer.

It was Trumbo’s 21st homer, which ranks eighth in the AL and is very impressive pop from a rookie. On the other hand, Trumbo is old for a rookie at 25 and his power comes with a ghastly .297 on-base percentage and 80/19 K/BB ratio.

Trumbo is on pace to hit 30 homers with an on-base percentage below .300, which is something only 17 hitters in baseball history have accomplished. Actually, only 14 different hitters, since Dave Kingman did it four times. Here’s the list of 30-homer, sub-.300 OBP seasons during the past 20 years:

                  YEAR      OBP     HR
Mike Jacobs       2008     .299     32
Chris Young       2007     .295     32
Tony Batista      2004     .272     32
Jeromy Burnitz    2003     .299     31
Jose Valentin     2004     .287     30

Oddly, no one hit 30 homers with a sub-.300 OBP during the 1990s, but it happened five times in the 2000s and seven times in the 1980s.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.